R&D Systems™ Recombinant Human CEACAM-8/CD66b Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CEACAM-8/CD66b Protein is derived from NS0. The Recombinant Human CEACAM-8/CD66b Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P31997
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 1088
• Molecular Weight (g/mol): 32kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human CEACAM-8/CD66b protein Gln35-Asp320,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Gene Alias: Carcinoembryonic antigen CGM6, carcinoembryonic antigen gene family member 6, carcinoembryonic antigen-related cell adhesion molecule 8, CD66b, CD66b antigen, CD67, CD67 antigen, CEACAM8, CGM6, NCA-95, Non-specific cross-reacting antigen NCA-95
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.